ImageneBio, Inc. (IMA) Free cash flow 2021–2024
ImageneBio, Inc. (IMA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$21.7MFY2024 · since FY2021: -$61.0M → -$21.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$21.7M | +73.2% |
| FY2023 | -$81.2M | -7.0% |
| FY2022 | -$75.9M | -24.3% |
| FY2021 | -$61.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice